|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K2317/24 | (2013.01) | ||
| C07K 16/28 | (2006.01) | ||
| C07K2317/33 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K 16/46 | (2006.01) | ||
| C07K 16/30 | (2006.01) | ||
| C07K2317/92 | (2013.01) | ||
| A61P 31/00 | (2006.01) | ||
| C07K 16/2827 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K 16/30 | (2013.01) | ||
| A61P 35/02 | (2006.01) | ||
| C07K2317/14 | (2013.01) | ||
| A61P 37/02 | (2006.01) | ||
| C07K2317/56 | (2013.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 37/02 | (2018.01) |
| (11) | Patento numeris | 3206711 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15784907.6 |
| Europos patento paraiškos padavimo data | 2015-10-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-08-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-05-31 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/055390 |
| Data | 2015-10-13 |
| (87) | Numeris | WO 2016/061142 |
| Data | 2016-04-21 |
| (30) | Numeris | Data | Šalis |
| 201462063852 P | 2014-10-14 | US | |
| 201462094847 P | 2014-12-19 | US | |
| 201562198545 P | 2015-07-29 | US | |
| 201562213076 P | 2015-09-01 | US |
| (72) |
FREEMAN, Gordon, James , US
SHARPE, Arlene, Helen , US
FREY, Gerhard, Johann , US
CHANG, Hwai, Wen , US
MATARAZA, Jennifer, Marie , US
DRANOFF, Glenn , US
|
| (73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
Dana-Farber Cancer Institute, Inc. , 450 Brookline Avenue, Boston, MA 02215-5450, US President and Fellows of Harvard College , 17 Quincy Street, Cambridge, MA 02138, US |
| (54) | ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF |
| ANTIBODY MOLECULES TO PD-L1 AND USES THEREOF |